XML 81 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:      
Net income $ 14,533 $ 11,645 $ 37,193
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 17,771 17,430 15,979
Provision for losses on accounts receivable 1,618 1,841 2,198
Stock-based compensation expense 2,153 6,583 3,162
Deferred income tax expense (benefit) 10,117 3,823 (11,651)
Amortization of deferred financing costs 392 532 820
Amortization of capitalized commissions on preneed contracts 558 599 0
Accretion of discount on convertible subordinated notes 241 2,192 4,329
Accretion of discount on senior notes 492 272 0
Net loss on early extinguishment of debt 0 502 0
Net loss (gain) on sale of businesses and disposal of other assets 4,096 1,052 (710)
Goodwill and other impairments 963 1,019 0
Gain on insurance reimbursements (879) 0 0
Other 121 0 0
Changes in operating assets and liabilities that provided (required) cash:      
Accounts and preneed receivables (5,801) (5,061) (4,254)
Inventories, prepaid and other current assets (2,762) (159) 1,446
Intangible and other non-current assets (251) (390) 149
Preneed funeral and cemetery trust investments (6,500) 488 2,373
Accounts payable (580) 2,044 (3,649)
Accrued and other liabilities 1,271 3,990 (385)
Deferred preneed funeral and cemetery revenue 168 6,546 1,446
Deferred preneed funeral and cemetery receipts held in trust 5,495 (5,954) (3,216)
Net cash provided by operating activities 43,216 48,994 45,230
Cash flows from investing activities:      
Acquisitions and land for new construction (140,907) (37,970) (28,799)
Deposit on pending acquisition (5,000) 0 0
Proceeds from insurance reimbursements 1,433 0 0
Net proceeds from sale of businesses and other assets 967 0 5,731
Capital expenditures (15,379) (13,526) (16,395)
Net cash used in investing activities (158,886) (51,496) (39,463)
Cash flows from financing activities:      
Payments against the term loan 0 (127,500) (11,250)
Borrowings from the credit facility 174,961 124,500 106,900
Payments against the credit facility (118,261) (189,400) (82,600)
Payment of debt issuance costs related to the credit facility 891 1,751 0
Redemption of the 2.75% convertible subordinated notes (27) (98,266) 0
Payment of transaction costs related to the redemption of the 2.75% convertible subordinated notes 0 (885) 0
Proceeds from the issuance of the 6.625% senior notes 76,688 320,125 0
Payment of debt issuance costs related to the 6.625% senior notes (980) (1,367) 0
Payments on long-term debt and obligations under finance leases (2,287) (1,940) (1,962)
Payments on contingent consideration recorded at acquisition date (162) (138) (101)
Proceeds from the exercise of stock options and employee stock purchase plan contributions 1,445 1,246 1,496
Taxes paid on restricted stock vestings and exercise of non-qualified options (194) (651) (509)
Dividends paid on common stock (5,398) (5,513) (3,709)
Purchase of treasury stock (9,152) (16,266) (16,366)
Net cash provided by (used in) financing activities 115,742 2,194 (8,101)
Net increase (decrease) in cash and cash equivalents 72 (308) (2,334)
Cash and cash equivalents at beginning of year 644   $ 952
Cash and cash equivalents at end of year 716 644  
Senior Notes [Member]      
Adjustments to reconcile net income to net cash provided by operating activities:      
Amortization of deferred financing costs 100    
Accretion of discount on senior notes $ 500 $ 300